Intranasal GM-CSF enhances efficacy of local ACNU delivery rendezvousing with TMZ plus irradiation in glioblastoma

Dong-Yi Yang; Xing-Yao Bu; Xue Cheng; Zhao-Yue Yan; Ming-Qi Qu; Yue-Wu Zhao; Ling-Fei Kong; Yao-Wei Wang; Jian-Chao Luo

doi:10.18632/oncotarget.24184

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/12/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Intranasal GM-CSF enhances efficacy of local ACNU delivery rendezvousing with TMZ plus irradiation in glioblastoma

Dong-Yi Yang, Xing-Yao Bu _, Xue Cheng, Zhao-Yue Yan, Ming-Qi Qu, Yue-Wu Zhao, Ling-Fei Kong, Yao-Wei Wang and Jian-Chao Luo

Dong-Yi Yang1, Xing-Yao Bu1, Xue Cheng4, Zhao-Yue Yan1, Ming-Qi Qu1, Yue-Wu Zhao2, Ling-Fei Kong2, Yao-Wei Wang3 and Jian-Chao Luo3

1Department of Neurosurgery, Zhengzhou University People's Hospital, Zhengzhou 450003, China

2Department of Pathology, Zhengzhou University People's Hospital, Zhengzhou 450003, China

3Department of Radiotherapy, Zhengzhou University People's Hospital, Zhengzhou 450003, China

4Department of Respiration, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China

Correspondence to:

Xing-Yao Bu, email: [email protected]

Keywords: glioblastoma; GM-CSF; Intranasal; rendezvous chemoradiotherapy; survival

Received: July 08, 2017 Accepted: January 02, 2018 Epub: January 12, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24184

Publication Alerts

Post-Publication Promotion

Publication Discount

Withdrawal Notice

Research Papers:

Intranasal GM-CSF enhances efficacy of local ACNU delivery rendezvousing with TMZ plus irradiation in glioblastoma